Microcap Stock News Zennie62 on YouTube.com

Another micro-cap biotech has flunked a pivotal test for a regenerative cell therapy – Endpoints News

Endpoints NewsToday the failure belongs to Cytori Therapeutics $CYTX which says that the cells it extracted from patients’ fat failed to hit either the primary or secondary endpoints in a Phase III comparison with placebo in treating scleroderma. Most of the … and more …read more Source:: MicroCap Stock News From Google News

from WordPress http://ift.tt/2gX6h1k
Post A Comment
  • Blogger Comment using Blogger
  • Facebook Comment using Facebook
  • Disqus Comment using Disqus

No comments :

Popular Posts

three columns